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SUMMARY
Periodontitis is a polymicrobial oral infection
characterized by the destruction of tooth-support-
ing structures that can be linked to systemic dis-
eases such as cardiovascular disease, diabetes
or rheumatoid arthritis. Porphyromonas gingiva-
lis, a bacterium implicated in the etiology of peri-
odontitis, has shown variation in inducing T-cell
responses among different strains. Therefore, in
this study we investigated the strain-specific
immune response using a murine experimental
model of periodontitis. Periodontitis was induced
by P. gingivalis strains A7A1-28, W83 and W50,
and later confirmed by the presence of P. gingiva-
lis in the oral microflora and by alveolar bone
resorption. Splenocytes were evaluated for gene
expression, cellular proteins and cytokine expres-
sion. Dendritic cells were stimulated in vitro for T
helper cell–cytokine profiling. Results showed
that P. gingivalis had the ability to alter the sys-
temic immune response after bacterial exposure.
Strains W50 and W83 were shown to induce alve-
olar bone loss, whereas the A7A1-28 strain did
not significantly promote bone resorption in mice.
Splenocytes derived from mice infected with
strains W50 and W83 induced expression of
high levels of interleukin-4 (IL-4) but A7A1-28
stimulated increased IL-10. Stimulation of den-
dritic cells in vitro showed a similar pattern of
cytokine expression of IL-12p40, IL-6 and trans-
forming growth factor-b among strains. A distinct
systemic response in vivo was observed among
different strains of P. gingivalis, with IL-10 associ-
ated with the least amount of alveolar bone loss.
Evaluation of pathogen-driven systemic immune
responses associated with periodontal disease
pathogenesis may assist in defining how
periodontitis may impact other diseases.
INTRODUCTION
Periodontal disease is an immuno-inflammatory infec-
tion of the tooth-supporting structures and a major
cause of tooth loss among the adult population.
Increasing evidence shows an association between
periodontal disease and other diseases, including car-
diovascular disease (Friedewald et al., 2009), diabe-
tes mellitus (Lamster et al., 2008) and rheumatoid
arthritis (De Pablo et al., 2009). Although this associ-
ation seems to be bi-directional, studies show that
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periodontitis alone can be considered a modifying
factor for human diseases (Garlet, 2010). Still, the
mechanism causing this effect is not well defined and
the systemic immunological influence of periodontal
disease is not clearly understood.
The acquired immune response is known to be
important for periodontal disease development (Garlet,
2010). Specific microbial components that activate
antigen-presenting cells, such as dendritic cells, will
lead to production of a set of cytokines. The pattern of
cytokines expressed determines subsequent polariza-
tion of a distinct antigen-specific lymphocyte response.
Characteristic markers of T helper type 1 (Th1), Th2,
Th17 and regulatory T (Treg) cell subsets have all
been described in diseased periodontal tissues (Garlet
et al., 2003). Therefore, the exact crosstalk that occurs
among Th cytokines in periodontal disease and its
impact on disease outcome is still to be determined.
However, it is clear that Th cells are essential for peri-
odontal destruction. The absence of B cells does not
impede lipopolysaccharide-induced bone resorption
(Yamaguchi et al., 2008). But B cells also seem to con-
tribute to periodontal disease development; B-cell dele-
tion prevented alveolar bone loss in mice after infection
with Porphyromonas gingivalis (Baker et al., 2009).
Porphyromonas gingivalis is a pathogenic bacterium
associated with increased risk to periodontal break-
down, disease recurrence (Socransky et al., 1998,
2002; Byrne et al., 2009). Colonization by P. gingivalis
can cause changes in the amount and composition of
the oral commensal microbiota by perturbing the host
immune response (Hajishengallis et al., 2011). Several
strains of P. gingivalis have been isolated from individ-
uals with oral infections and are used to understand
periodontal disease pathogenesis. Some studies have
directly compared the biological differences induced
among P. gingivalis strains in animal models. Classi-
cally, P. gingivalis strains are classified as invasive or
non-invasive strains based on differences in the ability
to cause soft-tissue abscesses following subcutaneous
injections at distant or local sites (Neiders et al., 1989).
In addition to soft-tissue abscesses, different strains
vary in their ability to cause periodontal bone loss
(Baker et al., 2000), serum and saliva antibody expres-
sion (Katz et al., 1996) and death in mice (Ebersole
et al., 1995) and Drosophila (Igboin et al., 2011). Only
36% of mice gavaged with strain A7A1-28 died but
W50 strain caused death in 100% of the animals in a
48-h period (Katz et al., 1996), demonstrating the dif-
ferent pathogenic potential of these strains. In addition,
the induced pattern of cytokines driving the develop-
ment of Th cells in vitro has also shown differences
among strains (Gemmell et al., 2002; Vernal et al.,
2009). Therefore, we speculate that the systemic effect
following an oral infection with different P. gingivalis
strains is also distinct. In this study, we established
periodontal infection in mice with the strains A7A1-28,
W83 and W50, and hypothesized that, along with the
differences found in the amount of alveolar bone loss
established, P. gingivalis would induce a distinct pat-
tern of systemic immune responses among strains.
The P. gingivalis strains chosen in this study are
among the predominant ones isolated from clinical
samples and are used as inducers of periodontitis in
preclinical models of disease (Igboin et al., 2009).
METHODS
To evaluate the systemic immune response caused
by different P. gingivalis strains, the strains A7A1-28,
W83 and W50 were tested both in vivo and in vitro.
All animal experiments were approved by the Institu-
tional Animal Care and Use Committee of the Univer-
sity of Michigan and conformity to ARRIVE guidelines
for preclinical studies. In vivo, DBA/1J mice (The
Jackson Laboratory, Bar Harbor, ME) were infected
with the three different strains and followed during
42 days for periodontal disease development (Fig. 1).
Periodontal disease was confirmed by the presence
of P. gingivalis in the oral cavity by polymerase chain
reaction (PCR) and the stimulation of bone loss
assessed by micro-computed tomography (micro-CT)
and histomorphometric analysis. In addition, spleno-
cytes were collected and evaluated by flow cytometry
and gene expression, as well as being treated with
phorbol 12-myristate 13-acetate (PMA)/ionomycin and
evaluated for protein expression by enzyme-linked
immunosorbent assay (ELISA). In vitro, bone-marrow-
derived dendritic cells from non-infected mice were
isolated and activated with different P. gingivalis
strains, and later evaluated for protein expression by
ELISA.
Bacterial strains
Porphyromonas gingivalis strains A7A1-28, W83 and
W50 were grown under anaerobic conditions (85%
N2, 5% CO2 and 10% H2) on pre-reduced brucella
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broth agar (BD Biosciences, San Jose, CA) plates
enriched with 5% sheep blood (Remel, Lenexa, KS),
5 mg ml1 hemin and 1 lg ml1 menadione (Sigma-
Aldrich, St Louis, MO). The P. gingivalis colonies
were confirmed by PCR of Arg-gingipain (201 base
pairs) and DNA sequencing before experiments were
performed. Before PCR analysis was performed, the
samples were heated at 100°C for 30 min. The fol-
lowing primer was used: 5′-CAAAATTACTCCGGGG
ATCA-3′ (forward) and 5′-GCCGAAGCAATACAAA
GAGC-3′ (reverse). New bacterial passages were fur-
ther confirmed by the presence of homogeneous
black-pigmented colonies or BANA test positivity
(Loesche et al., 1992).
Murine periodontitis model
Thirty-two DBA/1J male mice (4 weeks old) were
divided into four groups (eight mice/group) that were
infected with A7A1-28, W83, W50 or vehicle. Mice
were given sulphamethoxazole at 0.87 mg ml1 and
trimethoprim at 0.17 mg1ml (Hi-Tech Pharmacal Co.
Inc., Armityville, NY) in mili-Q water ad libitum for
10 days, followed by 3 days without antibiotics. For
infection, P. gingivalis was suspended at 1010 colony-
forming units (CFU) ml1 as determined by optical
density at 600 nm. Mice were inoculated with
109 CFU of bacteria in 100 ll phosphate-buffered sal-
ine with 2% carboxymethylcellulose (Sigma-Aldrich,
St Louis, MO) by oral gavage on six separate occa-
sions, with 2-day intervals as previously described
(Baker et al., 1999; Sasaki et al., 2008). The vehicle
group received carboxymethylcellulose alone. Mice
were weighed at study initiation and at sacrifice
(Fig. 1).
Oral microflora analysis
For P. gingivalis colonization analysis, the oral micro-
flora was collected at baseline and 1, 7, 14, 21, 28
and 42 days after the last gavage. A sterile swab
was placed in the oral cavity of mice and swirled for
15 s before being placed in 1 ml phosphate-buffered
saline. Bacterial infection was confirmed by PCR of
Arg-gingipain. To identify the minimum amount of
bacteria detectable in the oral microflora of mice,
PCR analysis was performed with P. gingivalis at the
following concentrations: 0, 102, 103, 104 CFU ml1.
The PCR products were evaluated by electrophoresis
and densitometry by IMAGEJ software (http://rsb.info.
nih.gov/ij/download.html).
Micro-computed tomography
Mice were sacrificed at 42 days following gavage and
subsequently maxillae were harvested and immedi-
ately fixed in 10% formalin for 24 h, and transferred
to 70% alcohol. Fixed, non-demineralized mouse
maxillae were scanned using a Pxs5-928EA cone-
beam micro-CT system for the generation of three-
dimensional images (GE Healthcare, Little Chalfont,
UK). Analysis was performed by a calibrated masked
examiner (SL). All micro-CT maxillary images were
reoriented with morphological landmarks identified as
previously described (Park et al., 2007). All three
planes were identified by morphological landmarks to
Figure 1 Schematic diagram illustrating the study experimental design. This timeline displays the in vivo experiment, including mice acclima-
tion, antibiotic treatment, Porphyromonas gingivalis (Pg) infection period and periodontitis developmental (PD) phase, oral microflora sampling,
spleen harvest and sacrifice.
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ensure consistent orientation. The region of interest
(ROI) was then chosen to include as much interproxi-
mal alveolar bone while excluding tooth structures.
Two transverse plane boundaries of ROI were cho-
sen between the M1 root furcation and the root apex
of M1 and M3. Tissue mineral content, bone volume,
bone volume fraction and bone mineral content were
obtained using bone analysis command of GEHC
MICROVIEW ANALYSIS PLUS software (GE Healthcare), as
previously described (Park et al., 2007).
Histological preparation and analysis
After analysis by micro-CT, maxillae were decalcified
in EDTA (Acros Organics, Fair Lawn, NJ) for a period
of 14 days and then embedded in paraffin. Sagittal
sections (4–5 lm thick) were obtained from each
maxilla at the molar region of M1, M2 and M3 for
two-dimensional evaluation. Coded sections were
stained with hematoxylin & eosin for histomorpho-
metric analysis, further performed by a masked and
calibrated examiner (JM). The distance between the
cementum–enamel junction and the alveolar bone
crest in the mesial and distal region of M1 with mesial
of M2 were measured using NIS ELEMENTS BASIC
RESEARCH imaging software (Nikon Inc., Melville, NY)
(Park et al., 2011).
Spleen harvest and processing
After mice were sacrificed, spleens were removed,
segmented and placed in 10 ml serum-free RPMI -
1640 medium (Gibco, Life Technologies, Grand
Island, NY). Cells were dispersed through a 70-lm
cell strainer into a 50-ml conical tube and centrifuged
at 480 g for 3 min. The pellet was suspended in 5 ml
ACK lysis buffer (155 mM NH4Cl, 10 mM KHCO3,
0.1 mM EDTA) for 5 min to allow for lysis of red blood
cells. Serum-free medium was added to halt lysis;
supernatant was collected and centrifuged at
480 RCF for 5 min to pellet the leukocytes. The total
number of splenocytes was calculated and further
experiments were performed.
Quantification of splenocyte messenger RNA
expression
Processed splenocytes derived from mice 42 days
after gavage were treated with 1 ml TRIzol reagent
(Invitrogen, Rockville, MD) and stored at  80°C for
messenger RNA (mRNA) expression and further
analysis. The RNA was isolated via the TRIzol
method, and total RNA was quantified by spectropho-
tometry. Double-stranded complementary DNA
(cDNA) was synthesized from 0.5 lg RNA using the
High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Carlsbad, CA). The cDNA was
amplified via TaqMan Universal PCR Master Mix
(Applied Biosystems). The following transcription fac-
tors were evaluated: T-bet for a Th1-driven response,
GATA-3 for a Th2-driven response, Ror-c for a Th17-
driven response, Foxp3 for a Treg-cell-driven cell
response, and FasL for a killer cell response. Amplifi-
cation was performed using the ABI Prism 7700
Sequence Detection System (Applied Biosystems).
Gene expression was normalized with the house-
keeping gene GAPDH and relative quantification of
the data generated was carried out using the compar-
ative CT method (Schmittgen & Livak, 2008).
Flow cytometric analysis
Splenocytes were isolated and labeled with either
anti-mouse CD3-phycoerythrin (PE)-cychrome 7
(Cy7) conjugate (BD Biosciences) and anti-mouse
CD4-fluorescein isothiocyanate (Biolegend, San
Diego, CA) for T cells or B220-PE-Cy7 conjugate,
CD5-allophycocyanin (APC) and FasL-PE (BD Bio-
sciences) for killer B cells, followed by fixation in Fix-
Perm buffer (Biolegend, San Diego, CA) overnight at
4°C. Fixation solution was washed thoroughly fol-
lowed by labeling of cells with FoxP3-PE, interleukin-
17 (IL-17) -APC, or IL-10-PE (EBiosciences, San
Diego, CA) for T cells. Flow cytometry was performed
on a Cytomics FC 500 flow cytometer (Beckman
Coulter, Fullerton, CA), and cell marker analysis
was performed using FLOJO software (TreeStar Inc.,
Ashland, OR).
Splenocyte cultures for analysis of cytokine
expression
Splenocytes were plated in 12-well plates at
5 9 106 cells ml1 in RPMI-1640 medium supple-
mented with 10% fetal bovine serum, 1% penicillin/
streptomycin (Gibco), 1% HEPES (Gibco), 1%
sodium pyruvate (HyClone, South Logan, UT) and
0.1% 2-mercaptoethanol (Gibco). Cells were treated
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with PMA/ionomycin (Sigma-Aldrich) for B-cell and
T-cell activation. The PMA/ionomycin mimics antigen
receptor activation and elicits cytokines from previ-
ously activated lymphocytes, with usually higher
degrees of expression compared with antigen reacti-
vation. Cell-free supernatants were collected after
48 h of treatment from cultures and evaluated
by ELISA for interferon-c (IFN-c) for Th1-driven
response, IL-17 (BD Biosciences) and IL-6 (R&D
Systems, Minneapolis, MN) for Th17-driven response,
IL-10 and transforming growth factor-b (TGF-b) (R&D
Systems) for Treg cell response, IL-4 (R&D Systems)
for Th2 cell response according to the manufacturer’s
protocol.
Dendritic cell activation
To evaluate the cytokine production from antigen-pre-
senting cells, bone-marrow-derived dendritic cells
were isolated as previously described and activated
with different strains of P. gingivalis (Lutz et al.,
1999). Briefly, murine hind limbs from non-infected
DBA/1J male mice were collected. Bone marrow was
flushed with RPMI-1640 supplemented with 10 lg
granulocyte–macrophage colony-stimulating factor,
10% fetal bovine serum, 1% penicillin/streptomycin,
and 0.1% 2-mercaptoethanol (Sigma-Aldrich). To
obtain dendritic cells with high percentage purity, the
flushed bone marrow was cultivated for 10 days and
plated at 105 cells per well. Cells were treated with
the different strains of P. gingivalis at multiplicity of
infection of 0.1, 1 and 10 for 1 h, followed by treat-
ment with gentamycin at 50 lg ml1. Supernatants
were collected after 18 h for cytokine expression
analysis. To evaluate the immune response driven by
P. gingivalis infection, cytokine expression was evalu-
ated by ELISA for IL-12p40, IL-6 and TGF-b (BD Bio-
sciences) for Th1 and Th17 activation, and Treg cell
response, respectively.
Statistical analysis
The preclinical studies consisted of eight animals per
group at the 42-day analysis. Dendritic cell experi-
ments were performed in triplicates. The differences
among groups were statistically assessed by analysis
of variance (significance defined as P < 0.05), with
Tukey multiple comparison post hoc test. Groups of
infected mice were compared with those given
vehicle alone by t-test. Data were analysed using the
GRAPHPAD PRISM 5.0 program (GraphPad Software, La
Jolla, CA).
RESULTS
Periodontal disease establishment and
development
Colonies of P. gingivalis were confirmed by PCR of
Arg-gingipain (201 bp) (Fig. 2A) and DNA sequenc-
ing. To evaluate the number of P. gingivalis CFU nec-
essary in the oral microflora of mice for their
detection by PCR of Arg-gingipain, known amounts of
P. gingivalis were added to mouse oral samples at 0,
102, 103, 104 CFU. The presence of 102 CFU P. gin-
givalis was not detectable in the oral microflora by
PCR, but the presence of 103 and 104 CFU was suffi-
cient for P. gingivalis detection (Fig. 2B). At baseline
before oral gavage, we evaluated the oral microflora
by PCR of Arg-gingipain, and all mice were negative
for the presence of P. gingivalis (Fig. 2C). The PCR
evaluations of the oral samples demonstrated P. gin-
givalis infection at all time-points evaluated. At
42 days after the last gavage was performed, 22 of
24 mice were infected with P. gingivalis (Fig. 2D–F).
Only one mouse from groups W83 (Fig. 2E) and W50
(Fig. 2F) failed to demonstrate P. gingivalis confirma-
tion at the end of the experiment. When evaluated by
band intensity, W83 showed the highest amount of
recovery from the oral cavity, followed by A7A1-28
and W50 strains. None of the mice in the vehicle
group was positive for P. gingivalis. No differences
were found in weight gain by mice among groups,
with a mean 44.46% weight gain.
For alveolar bone analysis by micro-CT (Fig. 3A),
all four bone-related parameters evaluated showed a
significant difference among groups (analysis of vari-
ance P < 0.05). For tissue mineral content, bone vol-
ume and bone mineral content, a statistical difference
was observed between groups W50 and vehicle
(Tukey P < 0.05). A higher loss was observed in
W50-infected animals by tissue mineral content mea-
surements with 14.1% loss (Fig. 3B), followed by
11.6% loss by bone volume analysis (Fig. 3C), and
11.4% loss of bone mineral content (Fig. 3D) com-
pared with vehicle group. Mice gavaged with W83
strain presented statistically significant differences in
bone loss compared with vehicle group (Tukey
© 2012 John Wiley & Sons A/S 487
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P < 0.05) when evaluated for tissue mineral content
with 14.3% loss (Fig. 3B), and for bone volume frac-
tion with 7.9% loss (Fig. 3E). A7A1-28-infected ani-
mals showed a trend of bone loss compared with
vehicle among all parameters with a tissue mineral
content loss of 6.6%. However, these differences did
not reach statistical significance. The vehicle group
consistently showed the highest volumetric amount of
alveolar bone among all groups when evaluated by
all four parameters.
Histomorphometric analysis performed in the mesial
region of M1 showed that the distance between the
alveolar bone crest and the cementum–enamel junc-
tion was significantly higher in W83-infected animals
when compared with vehicle (Tukey, P = 0.008) fol-
lowed by A7A1-28-infected animals and W50-infected
animals (Fig. 4). Measurements performed in the
interproximal region of M1 and M2 showed W50 with
the greatest degree of bone loss (103.47 ± 33.2 lm),
followed by A7A1-28 (94.23 ± 25.7 lm), W83
(90.8 ± 24.9 lm) and vehicle (82.6 ± 20.4 lm).
Systemic immune response
At 42 days post-gavage, splenocyte numbers were
similar among groups with an average of
8.9 9 107 cells per mouse. Non-activated spleno-
cytes from control and P. gingivalis-infected mice
did not show differences in the mRNA expression
of the transcription factors Tbx-21, Gata-3, ROR-c,
Foxp3 or FasL (data not shown). In addition,
CD3+ CD4+ non-activated T cells were similar
among groups when intracellular staining for Foxp3
and IL-10 for a Treg cell response or FasL expres-
sion for a killer cell response was evaluated. A
trend towards an increase of CD3+ CD4+ Foxp3+
cell percentage was observed in P. gingivalis-
infected mice (Fig. 5). However, a higher percent-
age of CD3+ CD4+ Foxp3+ was observed in the
groups of infected mice compared with vehicle-
treated mice (P = 0.019). When splenocytes were
evaluated for the expression of CD5+ B220+ cells, a
higher percentage was found in mice gavaged with







Figure 2 Polymerase chain reaction (PCR) analysis of Porphyromonas gingivalis oral infection determined by Arg-gingipain (201 bp). (A)
Confirmation of P. gingivalis colonies of strains W83, W50 and A7A1-28 before gavage. (B) Porphyromonas gingivalis colony-forming units
(CFU) at 0, 102, 103 and 104 were added to a sample collected from the oral microflora of mice to determine the detection limit via PCR. Oral
microflora analysis: samples of mice infected with P. gingivalis at baseline (upper panel) and at 42 days after the first gavage (lower panel).
Numbers 1 to 8 represent individual mice gavaged with (C) vehicle alone, (D) A7A1-28, (E) W83 and (F) W50.
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(P < 0.0001) (Fig. 5D). Interestingly, splenocytes
stimulated with 1% PMA/ionomycin showed a dis-
tinct pattern of cytokine expression (Fig. 6). Mice
gavaged with the A7A1-28 strain had a significantly
higher expression of IL-10 compared with vehicle
and mice gavaged with W83 strain (P = 0.0006). A
higher expression of IL-4, was found in both W83
and W50 groups with a significantly lower expres-
sion in the A7A1-28 group and vehicle (P = 0.04).
The expression of IFN-c was significantly lower in
the W83-infected animals when compared with
either vehicle or the A7A1-28-infected animals
(P = 0.01). No differences were found among
groups for the expression of the cytokines IL-17, IL-
6 or TGF-b (Fig. 6).
Innate immune response
Dendritic cells stimulated in vitro with the three strains
of P. gingivalis showed expression of IL-12p40, IL-6
and TGF-b, in a dose-dependent manner with no dif-
ferences observed among strains (Fig. 7).
DISCUSSION
An estimated 48.2% of American adults have peri-
odontal disease, which is the major cause of tooth
loss among adults (Albandar, 2011). Porphyromonas
gingivalis is an important bacterium involved in dis-
ease pathogenesis by inducing a local chronic host
inflammatory response that leads to alveolar bone
destruction. Our study demonstrated multiple patho-
genic differences among different P. gingivalis strains.
This could be important for understanding the rela-
tionship between oral and systemic diseases affected
by P. gingivalis infection. A difference in both alveolar
bone resorption and the systemic acquired immune
response was found among different strains of P. gin-
givalis. Mice gavaged with strains W50 and W83 had
a predominantly systemic IL-4 response (Fig. 6D) and
higher amount of local alveolar bone loss compared
with mice given vehicle only (Fig. 3). Mice gavaged
with strain A7A1-28 had predominantly systemic pro-
duction of IL-10 and IFN-c (Fig. 6) with less induction
of local alveolar bone loss (Fig. 3). Interestingly, the
A B C
D E
Figure 3 Alveolar bone loss measured by micro-computed tomography. (A) Representative images of the alveolar bone loss found in mice at
42 days after gavage was performed with the three different strains A7A1-28, W83 and W50. (B) Analysis performed for tissue mineral con-
tent, bone mineral content, bone volume and bone volume fraction. Error bars indicate standard error. Asterisks denote differences found
among groups by Tukey test (P < 0.05).
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genetically closely related strains W83 and W50 dis-
played more similar results, while strain A7A1-28,
which shows a divergence in the genome of 3.5%,
had a correspondingly more distinct response (Igboin
et al., 2009).
It is interesting to note that the absence of a signifi-
cant local oral response to A7A1-28 strain did not
translate into a lack of an in vitro or systemic
response. Although strain A7A1-28 failed to induce
bone loss, it resulted in potent dendritic cell
responses in vitro, as well as in IL-17 induction. Inter-
estingly, strains W83 and W50 induced significant
oral bone loss but less splenic cytokine expression.
Based on the results, we speculate that it would be
interesting to separate patient samples based on
P. gingivalis strains when evaluating the systemic
effects of periodontitis.
Interleukin-10 is an important immune regulatory
cytokine that has been shown to regulate both IFN-c-
driven and IL-4-driven immune responses (Hoffmann
et al., 2000). IL-10/ mice show severe alveolar bone
loss when infected with P. gingivalis (Sasaki et al.,
2004). Kobayashi et al. (2011) showed that gingival
mononuclear cells stimulated with PMA/ionomycin in
vitro had upregulated IL-10 production 30 days after
infection with P. gingivalis strain 33277, which was not
observed at the early time points of 1, 7 and 15 days.
Importantly, IL-10 polymorphisms that may be associ-
ated with differing levels of IL-10 expression are related
to periodontal disease progression clinically (Cullinan
et al., 2008). In alignment with our findings, these stud-
ies suggest that IL-10 is an important molecule in the
balance between inflammatory, humoral and infection
responses with P. gingivalis.
Figure 4 Histomorphometric image analysis performed in maxillae sections of mice at 42 days after gavage; the distance between the alveo-
lar bone crest to the cementum–enamel junction in M1 was measured in micrometers (depicted with black arrows) (hematoxylin & eosin,
209).
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Mice gavaged with strain A7A1-28 displayed less
bone loss and higher expression of IL-10 from
re-stimulated spleen cells, so we investigated whether
regulatory T and B cells were distinctively upregulat-
ed in the spleen. All strains of P. gingivalis showed a
trend toward induction of splenic Foxp3+ T cells
(Fig. 5A). Unexpectedly, the A7A1-28 group had the
lowest percentage of CD5+ B220+ cells (Fig. 5D), a
population of B cells reported to produce IL-10
(O’Garra & Howard, 1992; Haas et al., 2005; Yanaba
et al., 2008). CD5+ B cells have also been demon-
strated to express FasL in the presence of IL-4 and
IL-10, and to mediate T-cell death in an arthritic
model (Lundy & Boros, 2002; Lundy & Fox, 2009).
Despite differences in IL-10, IL-4 and CD5+ B cells,
we found no difference among groups in the mRNA
expression of FasL (Fig. 5C). Therefore, the higher
IL-10 expression from splenocytes derived from mice
gavaged with A7A1-28 strain could not be directly
attributed to either Breg or Treg cells. Further, no
change in splenic FasL expression could be attributed
to P. gingivalis infection. One possibility is that the
expression of IL-10 from splenocytes could be attrib-
uted to Foxp3 cells, such as the Treg 1 subset.
However, this strain does not express a definite pro-
totypic surface marker for exact identification (Pot
et al., 2011).
The importance of the acquired immune response
locally in periodontal bone loss has been demon-
strated by reduced bone loss in mice lacking both B
and T cells (Yamaguchi et al., 2008; Baker et al.,
2009). Porphyromonas gingivalis is an important bac-
terium commonly found in patients with periodontal
disease, and is associated with tissue breakdown
and disease recurrence (Socransky et al., 1998,
2002). The P. gingivalis strains A7A1-28, W83 and
W50 evaluated in this study are among the most pre-
valent strains found worldwide (Igboin et al., 2009),
and are therefore clinically relevant. The mouse
DBA1/J is a strain genetically suitable for induction of
inflammatory diseases, including arthritis, and paral-
lels the role of genetic loci as an important risk factor
for human rheumatoid arthritis. The susceptibility of
DBA/1J mice to arthritis is based on the MHC Class
II loci and the unique ability to present arthritis-associ-
ated antigens to T helper cells. To our knowledge,
there have been no studies published that suggest a
different response of these mice to toll-like receptor
A B
C D
Figure 5 Flow cytometric analysis of splenocytes derived from mice at 42 days after gavage with Porphyromonas gingivalis for regulatory
markers. (A) CD3+ CD4+ Foxp3+ cell percentage, (B) CD3+ CD4+ IL-10+ cell percentage, (C) mRNA FasL relative expression of non-activated
splenocytes (towards GAPDH), and (D) CD5+ B220+ cell percentage. Error bars indicate standard error. Asterisks denote differences found
among groups by Tukey test (*P < 0.05, **P < 0.001).
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antigens, such as P. gingivalis. Because rheumatoid
arthritis has been associated with periodontal disease
in patients (De Pablo et al., 2009), the systemic effect
of P. gingivalis in this strain of mice is important. We
used animals at 4 weeks of age to allow for the
development of a co-disease model that considers a
younger set of animals.
When P. gingivalis was evaluated for its presence in
the oral microflora by PCR analysis, W83 showed
higher band intensities, followed by strain A7A1-28
and W50 (Fig. 2). Similar to our findings, recovery of
W50 strain from the oral cavity of rodents using direct
bacteria cultivation was lower when compared with
strain A7A1-28, with only 17% being recovered
by 42 days in one of the studies (Baker et al., 2000;
Katz et al., 1996). Still, in accordance with Baker
et al. (2000), the differences found in the infection
assessment did not seem to influence the amount of
alveolar bone loss induced by the W50 strain. Our
results differ, however, in the amount of alveolar bone
loss observed at the end of the experiment by different
strains. Baker et al. (2000) found that strain A7A1-28
and W50 induced similar amounts of bone loss,
whereas in our study the A7A1-28 strain induced mini-
mal alveolar bone loss (Fig. 3). This finding could per-
haps be explained by the different methods used in
the studies to assess the alveolar bone level or differ-
ences between strains of mice. Although not directly
comparable, our micro-CT and histomorphometry data
were relatively congruent. The histomorphometry is a
classical method for evaluating bone loss and provides
histological visualization of the inflammatory process
in two dimensions while the micro-CT method provides







Figure 6 Cytokine expression of 42 days post-gavage murine splenocytes treated with phorbol 12-myristate 13-acetate (PMA)/ionomycin for
48 h in vitro. (A) Differences were found among groups for the expression of interleukin-10 (IL-10; P = 0.0006) and no differences for (B)
transforming growth factor-b (TGF-b); (C) interferon-c (IFN-c) expression was higher in A7A1-28 strain, and (D) IL-4 expression was higher in
W83 strain. No differences were found in expression of (E) IL-17 or (F) IL-6. Experiments were performed in duplicates. Error bars indicate
standard error. Asterisks denote differences found among groups by Tukey test (*P < 0.05, **P < 0.001).
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It is important to compare data generated in vitro
with in vivo results to determine the degree to which
cells generated in vitro truly reflect the biology of
responses generated under physiological, more com-
plex conditions. Our results show that while non-acti-
vated splenocytes from control and P. gingivalis-
infected mice did not show differences in the
expression of transcription factors, splenocytes that
were reactivated showed a strong distinct response.
This demonstrates that even though there was not an
active immune response happening in the spleen, the
exposure to P. gingivalis had a systemic effect dem-
onstrated by the ability to change the profile of sple-
nic cytokine expression upon cell reactivation. While
the dendritic cells stimulated in vitro had similar
responses among strains, with expression of IL-
12p40, IL-6 and TGF-b (Fig. 7), the in vivo scenario
was distinct (Fig. 6). A potential explanation for the
differences found between the in vitro and systemic
in vivo results is the changes in oral microflora that
occur when P. gingivalis is present, an alteration
called dysbiosis (Hajishengallis et al., 2011). Dysbio-
sis has the potential to impact the systemic immune
response and shown to be implicated in a variety of
diseases, including obesity, metabolic disorders, and
inflammatory bowel disease (Hill and Artis, 2010; Gar-
ret et al. 2010). Therefore, while the in vitro data are
a direct result of the effect of P. gingivalis in immune
cells, the in vivo data could be the result of changes
that occur in the amount and composition of the oral
microbiota due to P. gingivalis colonization. In accor-
dance with our results, Vernal et al. (2009) also did
not find differences in the pattern of cytokines
expressed by dendritic cells stimulated with different
serotypes of P. gingivalis in vitro, with all strains
showing expression of IFN-c, IL-1b, IL-12, tumor
necrosis factor, IL-6 and IL-10. However, we did not
observe a higher response to W83 when compared
with A7A1-28 (Fig. 7). This could be related to the dif-
ferences found in mRNA versus protein expression.
When the in vivo T-cell activation was evaluated, ani-
mals gavaged with P. gingivalis strain 33277 dis-
played stimulated splenocytes expressing high levels
of IFN-c, IL-2, IL-10 and IL-4, which was consistent
with a mixed Th1 and Th2 response (Katz et al.,
1999). Co-culture experiments using dendritic cells
and T cells also suggest a mixed Th1 and Th2
response (Jotwani & Cutler, 2004; Zeituni et al.,
2009). In agreement with our data, these studies sug-
gest that the Th cell type driving the in vivo response
of P. gingivalis is more complex than what can be
observed with single cell isolates in the in vitro envi-
ronment. The spleen is a secondary lymphoid organ
that contains approximately 55% B cells, 35% T cells
and 10% of other leukocytes, including macrophages
and natural killer cells. The spleen is a site of inter-




Figure 7 Dendritic cells stimulated with Porphyromonas gingivalis
strains A7A1-28, W83 and W50 at multiplicities of infection 1 : 10,
1 : 1, 1 : 0.1 showed an expression of (A) interleukin-12 (IL-12)
p40, (B) IL-6 and (C) transforming growth factor-b (TGF-b) in a
dose-dependent manner. Experiments were performed in dupli-
cates. Error bars indicate standard error.
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adaptive immune responses and is, therefore, an
important organ to be evaluated in the context of sys-
temic exposures to bacteria.
In summary, P. gingivalis had the ability to alter
the systemic immune response after bacterial expo-
sure. Strains W50 and W83 were shown to induce
alveolar bone loss, whereas strain A7A1-28 did not
significantly promote bone resorption in mice.
Splenocytes derived from mice infected with strains
W50 and W83 induced expression of high levels of
IL-4, whereas A7A1-28-stimulated splenocytes had
increased IL-10. Stimulation of dendritic cells in vitro
showed a similar pattern of cytokine expression of
IL-12p40, IL-6 and TGF-b among strains. A distinct
systemic response in vivo was observed among dif-
ferent strains of P. gingivalis, with IL-10 associated
with the least amount of alveolar bone loss. Evalua-
tion of pathogen-driven systemic immune responses
associated with periodontal disease pathogenesis
may assist in defining how periodontitis may impact
other diseases.
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